ConductScience.org, home

Paper42226962

Nanoparticle Drug Delivery Systems: The Future Direction for the Treatment of Tumors.

Zhao Y and 8 others. Int J Nanomedicine, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Nanoparticle Drug Delivery Systems: The Future Direction for the Treatment of Tumors. Papers, record 42226962. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226962

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanoparticle Drug Delivery Systems: The Future Direction for the Treatment of Tumors.
PubMed
Journal
Int J Nanomedicine
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhao YYan
2Nie XXin
3Yan HHongbo
4Ren JJingyuan
5Zhao JJianxin
6Tong LLage
7Zhao LLei
8Zhang GGuoxing
9Liu HHaifeng

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Antineoplastic AgentsMajor topic
Nanoparticle Drug Delivery SystemMajor topic
NanoparticlesMajor topic
Humans
Animals
Nanomedicine

Source PubMed

Download CSV of topics

References286

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130260234Current aspects in treatment of breast cancer based of nanodrug delivery systems and future prospects.Artif Cells Nanomed Biotechnol2018https://conductscience.org/library/papers/30260234PubMed
233809479Strategies for Cancer Treatment Based on Photonic Nanomedicine.Materials (Basel)2021https://conductscience.org/library/papers/33809479PubMed
336108810Liposomal oxaliplatin prodrugs loaded with metformin potentiate immunotherapy for colorectal cancer.J Control Release2022https://conductscience.org/library/papers/36108810PubMed
441794332Protein-based nanocarriers in the management of hard-to-treat solid tumours.Adv Drug Deliv Rev2026https://conductscience.org/library/papers/41794332PubMed
540177124Folic Acid-Targeted Liposome-Based Nanoparticle Loaded with Sorafenib for Liver Cancer Therapy.Int J Nanomedicine2025https://conductscience.org/library/papers/40177124PubMed
634740764Mechanisms of immune response to inorganic nanoparticles and their degradation products.Adv Drug Deliv Rev2022https://conductscience.org/library/papers/34740764PubMed
736796298Novel construction of multifunctional photo-responsive and nucleic acid-triggered doxorubicin-releasing liposomes for cancer therapy.Eur J Med Chem2023https://conductscience.org/library/papers/36796298PubMed
841326237CD47-targeted liposomal chemotherapy upregulates CD47 expression and induces microsatellite instability which enhances cancer immunotherapy.J Control Release2025https://conductscience.org/library/papers/41326237PubMed
932235073CD271 antibody-functionalized HGNs for targeted photothermal therapy of osteosarcoma stem cells.Nanotechnology2020https://conductscience.org/library/papers/32235073PubMed
1040412657VPS9D1-AS1 antisense therapy via lipid nanoparticles reprograms cold tumors and enhances immunotherapy in colorectal cancer.J Control Release2025https://conductscience.org/library/papers/40412657PubMed
1137551087Photoresponsive Inorganic Nanomaterials in Oncology.Technol Cancer Res Treat2023https://conductscience.org/library/papers/37551087PubMed
1234550040Topically applied liposome-in-hydrogels for systematically targeted tumor photothermal therapy.Drug Deliv2021https://conductscience.org/library/papers/34550040PubMed
1331698897Gradient Redox-Responsive and Two-Stage Rocket-Mimetic Drug Delivery System for Improved Tumor Accumulation and Safe Chemotherapy.Nano Lett2019https://conductscience.org/library/papers/31698897PubMed
1436944946Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics.J Nanobiotechnology2023https://conductscience.org/library/papers/36944946PubMed
1527291325Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and apoptosis.Sci Rep2016https://conductscience.org/library/papers/27291325PubMed
1631294482Toxic effects and involved molecular pathways of nanoparticles on cells and subcellular organelles.J Appl Toxicol2020https://conductscience.org/library/papers/31294482PubMed
1735195416NIR Activated Upper Critical Solution Temperature Polymeric Micelles for Trimodal Combinational Cancer Therapy.Biomacromolecules2022https://conductscience.org/library/papers/35195416PubMed
1837153517Iron/iron oxide-based magneto-electrochemical sensors/biosensors for ensuring food safety: recent progress and challenges in environmental protection.RSC Adv2023https://conductscience.org/library/papers/37153517PubMed
1923676854Roles of the hepcidin-ferroportin axis and iron in cancer.Eur J Cancer Prev2014https://conductscience.org/library/papers/23676854PubMed
2027292613Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer.Acta Pharmacol Sin2016https://conductscience.org/library/papers/27292613PubMed

See all 286 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42943973A Review of KSHV: Lifecycle, Tumorigenesis, Immune Evasion and Therapeutic Strategies.Viruses2026https://conductscience.org/library/papers/42943973PubMed
42793129Bufalin-Loaded Multifunctional Nanodrugs for Cancer Therapy: Mechanisms, Delivery Strategies, and Translational Perspectives.Biomolecules2026https://conductscience.org/library/papers/42793129PubMed
42657191Graphene and Graphene Oxide-Based Nanocarriers for Targeted Delivery of Mitoxantrone in Cancer Therapy.Int J Nanomedicine2026https://conductscience.org/library/papers/42657191PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42226962

GET https://conductscience.org/api/papers/v1/42226962/references?page=2